Cargando…

Increased Sclerostin Levels after Further Ablation of Remnant Estrogen by Aromatase Inhibitors

BACKGROUND: Sclerostin is a secreted Wnt inhibitor produced almost exclusively by osteocytes, which inhibits bone formation. Aromatase inhibitors (AIs), which reduce the conversion of steroids to estrogen, are used to treat endocrine-responsive breast cancer. As AIs lower estrogen levels, they incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Wonjin, Chung, Yoonjung, Kim, Se Hwa, Park, Sehee, Bae, Jae Hyun, Kim, Gyuri, Lee, Su Jin, Kim, Jo Eun, Park, Byeong-Woo, Lim, Sung-Kil, Rhee, Yumie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384667/ https://www.ncbi.nlm.nih.gov/pubmed/25827459 http://dx.doi.org/10.3803/EnM.2015.30.1.58

Ejemplares similares

The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
por: Kim, Se Hwa, et al.
Publicado: (2014)

Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease
por: Kim, Gyuri, et al.
Publicado: (2017)

Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients
por: Seo, Da Hea, et al.
Publicado: (2019)

Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
por: Park, Jin Young, et al.
Publicado: (2013)

Diagnosis of recurrent reflux within the remnant non-treatment stump after bilateral cyanoacrylate ablation of the great saphenous veins
por: Park, Seung Joon, et al.
Publicado: (2019)

Evaluation of the Privacy Risks of Personal Health Identifiers and Quasi-Identifiers in a Distributed Research Network: Development and Validation Study
por: Oh, SeHee, et al.
Publicado: (2021)

Expression and Regulation of Osteoprotegerin in Adipose Tissue
por: An, Juan-Ji, et al.
Publicado: (2007)

Primary Squamous Cell Carcinoma of the Remnant Stomach after Subtotal Gastrectomy
por: Chang, Yeon Soo, et al.
Publicado: (2016)

Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study
por: Hong, Namki, et al.
Publicado: (2021)

The Aromatase–Estrogen System in the Testes of Non-Mammalian Vertebrates
por: Rosati, Luigi, et al.
Publicado: (2021)

Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
por: Makarewicz, Jacek, et al.
Publicado: (2010)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Modifications of T-Scores by Quantitative Ultrasonography for the Diagnosis of Osteoporosis in Koreans
por: Rhee, Yumie, et al.
Publicado: (2009)

Clinicopathological Characteristics and Prognosis of Remnant Gastric Cancer
por: Lee, Sang Bong, et al.
Publicado: (2010)

Aromatase expression and role of estrogens in male gonad : a review
por: Carreau, Serge, et al.
Publicado: (2003)

A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
por: Lee, Eun Kyung, et al.
Publicado: (2020)

Effects of Oral Streptokinase-Streptodornase on Remnant Chronic Subdural Hematomas
por: Park, Min, et al.
Publicado: (2015)

Radioiodine Remnant Ablation: A Critical Review
por: Bal, Chandra Sekhar, et al.
Publicado: (2015)

Associations between Sclerostin and Anthropometric and Metabolic Parameters in Children and Adolescents
por: Kim, Shin-Hee, et al.
Publicado: (2021)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

MON-494 Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to the Treatment: Total Thyroidectomy Versus Total Thyroidectomy with Radioactive Iodine Remnant Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Decreased Serum Level of Sclerostin in Older Adults with Sarcopenia
por: Ahn, Seong Hee, et al.
Publicado: (2022)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
por: Kim, Jinuk, et al.
Publicado: (2020)

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice
por: Van Sinderen, Michelle L., et al.
Publicado: (2015)

Molecular Basis for Endocrine Disruption by Pesticides Targeting Aromatase and Estrogen Receptor
por: Zhang, Chao, et al.
Publicado: (2020)

Estrogen disorders: Interpreting the abnormal regulation of aromatase in granulosa cells (Review)
por: Liu, Ting, et al.
Publicado: (2021)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Site-Specific Regulation of Sulfatase and Aromatase Pathways for Estrogen Production in Endometriosis
por: Da Costa, Katiane de Almeida, et al.
Publicado: (2022)

Serum γ-Glutamyl Transferase Is Inversely Associated with Bone Mineral Density Independently of Alcohol Consumption
por: Choi, Han Seok, et al.
Publicado: (2016)

What influences aromatase inhibitor continuation intention among breast cancer survivors?
por: Seo, Young Kyung, et al.
Publicado: (2021)

Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors
por: Zava, David T, et al.
Publicado: (2021)

Author Correction: Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
por: Kim, Jinuk, et al.
Publicado: (2022)

Cervical chondrocutaneous remnant: a case report
por: Park, Dae Hwan, et al.
Publicado: (2022)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation Assessed by Proton MR Spectroscopy
por: Li, Shaojun, et al.
Publicado: (2019)

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

Articular cartilage chondrocytes express aromatase and use enzymes involved in estrogen metabolism
por: Schicht, Martin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0umo92a4nkoq3pvvuq2j8bftoq